衞光生物(002880.SZ):擬投資建設衞光生命科學園項目(二期)
格隆匯9月23日丨衞光生物(002880.SZ)公佈,為順應粵港澳大灣區和深圳市生物醫藥產業政策趨勢,瞄準全球生物醫藥產業的創新制高點和先進模式,與“雙區”、“雙中心”建設和“光明科學城”發展形成共振。公司擬投資建設衞光生命科學園項目(二期),預計投資約7.83億元。
地處光明科學城內,屬於M1用地,建設用地宗地號A525-0076,用地面積6.672萬平方米。建設內容:綜合性高科技生物醫藥產業園。建築面積16.68萬平方米,主要建設內容包括兩棟綜合性板塔結構產業及中試實驗廠房、一棟綜合性辦公樓、配套危化品臨時週轉倉庫等。
衞光生命科學園以創新、智慧、生態、共享為特色,以孵化、科研、服務為核心,聚焦生命科學創新前沿,打造生物產業集聚高地;以生物藥、醫療器械、先進治療技術為主要產業定位,通過建立中試服務平台、引入培育龍頭CRO/CDMO 機構、與上下游研究機構和企業建立戰略聯盟等方式,全方位鏈接產業資源,建立生命健康生態圈,支持成果轉化和創新項目成長。
該項目聚焦於產業鏈環節的前端成果轉化與中小企業孵化加速,將在醫療健康產業方面通過“研發+生產”的產業鏈分工實現科學城與其他區域之間的聯動,即主要承擔研發、中試製造環節,並配置部分生產環節,由此形成產業分工協作發展。建成後將從場地、技術、人員、政策、資金等方面給予入駐企業服務,從科技金融服務、公共技術服務及產業促進服務三大板塊搭建公共服務平台,助力創新型企業在園區內就能便捷的解決研發和產業化過程中遇到的問題,促進創新研發成果快速產業化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.